|
TMEM5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.695400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.048000E-04 |
| Normal-vs-Stage2 |
2.760400E-02 |
| Normal-vs-Stage3 |
6.799800E-01 |
| Normal-vs-Stage4 |
4.993200E-01 |
| Stage1-vs-Stage2 |
9.226800E-01 |
| Stage1-vs-Stage3 |
1.435630E-01 |
| Stage1-vs-Stage4 |
4.566100E-02 |
| Stage2-vs-Stage3 |
1.979210E-01 |
| Stage2-vs-Stage4 |
1.286440E-01 |
| Stage3-vs-Stage4 |
3.480200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.022700E-03 |
| Normal-vs-AfricanAmerican |
2.921000E-01 |
| Normal-vs-Asian |
5.818800E-01 |
| Caucasian-vs-AfricanAmerican |
3.409400E-01 |
| Caucasian-vs-Asian |
1.315360E-01 |
| AfricanAmerican-vs-Asian |
2.952400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.196600E-04 |
| Normal-vs-Female |
9.315800E-01 |
| Male-vs-Female |
2.269800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.098600E-03 |
| Normal-vs-Extreme_Weight |
1.143520E-03 |
| Normal-vs-Obese |
4.966400E-01 |
| Normal-vs-Extreme_Obese |
1.263850E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.781400E-01 |
| Normal_Weight-vs-Obese |
1.227640E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.701400E-01 |
| Extreme_Weight-vs-Obese |
8.893800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.312000E-01 |
| Obese-vs-Extreme_Obese |
1.145040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.245000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.286100E-02 |
| Normal-vs-Age(61-80Yrs) |
7.993800E-04 |
| Normal-vs-Age(81-100Yrs) |
7.259700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.162700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.677700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.215700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.904640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.562850E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.507200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.161600E-03 |
| Normal-VS-Type2 PRCC |
1.493920E-02 |
| Normal-VS-KIRP CIMP |
3.447200E-01 |
| Normal-VS-Unclassified PRCC |
1.827250E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.717800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.047700E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.108800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.275820E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.251600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.376500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.002200E-03 |
| Normal-vs-N1 |
1.089810E-01 |
| Normal-vs-N2 |
6.709200E-01 |
| N0-vs-N1 |
6.481800E-03 |
| N0-vs-N2 |
1.714950E-01 |
| N1-vs-N2 |
7.057200E-01 |
|
|
